According to our latest research, the global Human Immunodeficiency Virus (HIV) therapeutics market size in 2024 stands at USD 32.7 billion. The market is experiencing robust growth with a CAGR of 4.8% from 2025 to 2033. By the end of 2033, the market is forecasted to reach approximately USD 50.2 billion. This growth is primarily driven by the increasing prevalence of HIV infections worldwide, continuous advancements in antiretroviral therapies, and the growing focus on early diagnosis and treatment. As per the latest research, the market dynamics are being shaped by a combination of technological innovation, expanding healthcare infrastructure, and supportive government initiatives. https://growthmarketreports.com/report/human-immunodeficiency-virus-therapeutics-market-global-industry-analysis